The Library
C1q, the recognition subcomponent of the classical pathway of complement, drives microglial activation
Tools
Tools
Tools
Färber, Katrin, Cheung, Giselle, Mitchell, Daniel A., Wallis, Russell, Weihe, Eberhard, Schwaeble, Wilhelm J. and Kettenmann, Helmut (2009) C1q, the recognition subcomponent of the classical pathway of complement, drives microglial activation. Journal of Neuroscience Research, Vol.87 (No.3). pp. 644-652. doi:10.1002/jnr.21875
Research output not available from this repository, contact author.
Official URL: http://dx.doi.org/10.1002/jnr.21875
Abstract
Microglia, central nervous system (CNS) resident phagocytic cells, persistently police the integrity of CNS tissue and respond to any kind of damage or pathophysiological changes. These cells sense and rapidly respond to danger and inflammatory signals by changing their cell morphology; by release of cytokines, chemokines, or nitric oxide; and by changing their MHC expression profile. We have shown previously that microglial biosynthesis of the complement subcomponent C1q may serve as a reliable marker of microglial activation ranging from undetectable levels of C1q biosynthesis in resting microglia to abundant C1q expression in activated, nonramified microglia. In this study, we demonstrate that cultured microglial cells respond to extrinsic C1q with a marked intracellular Ca2+ increase. A shift toward proinflammatory microglial activation is indicated by the release of interleukin-6, tumor necrosis factor-alpha, and nitric oxide and the oxidative burst in rat primary microglial cells, an activation and differentiation process similar to the proinflammatory response of microglia to exposure to lipopolysaccharide. Our findings indicate 1) that extrinsic plasma C1q is involved in the initiation of microglial activation in the course of CNS diseases with blood-brain barrier impairment and 2) that C1q synthesized and released by activated microglia is likely to contribute in an autocrine/paracrine way to maintain and balance microglial activation in the diseased CNS tissue. (C) 2008 Wiley-Liss, Inc.
| Item Type: | Journal Article | ||||
|---|---|---|---|---|---|
| Subjects: | R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry | ||||
| Divisions: | Faculty of Medicine > Warwick Medical School > Biomedical Sciences > Translational & Experimental Medicine > Metabolic and Vascular Health (- until July 2016) Faculty of Medicine > Warwick Medical School |
||||
| Journal or Publication Title: | Journal of Neuroscience Research | ||||
| Publisher: | John Wiley & Sons Inc. | ||||
| ISSN: | 0360-4012 | ||||
| Official Date: | 15 February 2009 | ||||
| Dates: |
|
||||
| Volume: | Vol.87 | ||||
| Number: | No.3 | ||||
| Number of Pages: | 9 | ||||
| Page Range: | pp. 644-652 | ||||
| DOI: | 10.1002/jnr.21875 | ||||
| Status: | Peer Reviewed | ||||
| Publication Status: | Published | ||||
| Access rights to Published version: | Restricted or Subscription Access |
Data sourced from Thomson Reuters' Web of Knowledge
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
